Somavert (Pegvisomant Vials) 10mg

Somavert (pegvisomant) 10mg vials are prescribed for growth hormone excess management. This injectable medication helps regulate IGF-1 levels in adults. Store between 2-8°C to maintain potency. Consult a healthcare provider for suitability.

Strength

10mg

Pack Size

30s

Storage

2-8°

Manufacturer / TM Owner

Pfizer

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Somavert (pegvisomant) 10mg is used to treat acromegaly, a condition caused by excess growth hormone. It works by blocking growth hormone receptors to reduce IGF-1 levels. Patients often ask 'what is pegvisomant used for' to manage symptoms like enlarged hands or feet. It is prescribed when other treatments are ineffective.

Side Effects

Somavert (pegvisomant) 10mg vials help normalize IGF-1 levels over time. Users may notice reduced swelling or joint discomfort as symptoms improve. Individual responses vary, and regular monitoring is recommended. The medication is administered via injection, typically under medical supervision.

Precautions & Warnings

Keep Somavert (pegvisomant) 10mg refrigerated between 2-8°C to preserve efficacy. Protect vials from light and avoid freezing. Always check the solution for particles or discoloration before use. Discard any unused medication after the expiration date. Follow healthcare provider instructions for handling and disposal.

Avoid Interactions

Somavert (pegvisomant) 10mg may interact with insulin or diabetes medications, requiring dose adjustments. Avoid alcohol during treatment as it can affect blood sugar levels. Inform your doctor about all medications, including over-the-counter drugs. No known interactions with common pain relievers have been reported.

Frequently Asked Questions

Somavert is given as a subcutaneous injection, typically by a healthcare professional. Patients may learn self-injection techniques under medical guidance.

Common effects include injection site reactions, nausea, or fatigue. Severe reactions are rare but require immediate medical attention.

Somavert requires a prescription and is available through licensed pharmacies. Online purchases must comply with local regulations.

Symptom improvement varies; IGF-1 levels are monitored to assess effectiveness over several weeks or months.

Consult a healthcare provider before using pegvisomant if pregnant or breastfeeding. Safety data is limited in these populations.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.